Medical Nutrition Formulations Enriched With Postbiotics for the Management of Gastrointestinal Disorders

Efficacy and Tolerability of a Nutritional Supplementation With Medical Nutrition Formulations Enriched With Postbiotics for the Management of Gastrointestinal Disorders: a Pilot Trial

Efficacy and tolerability of ABB i5 prebiotic and ABB C22 postbiotics for the management of constipation and gastrointestinal well-being: a pilot trial

Inclusion Criteria:

• Inpatients of the centre

  • Diagnostic of diarrhoea: increase in daily faecal weight > 200 g (as per the Centre protocol).
  • Subjects who as per the Centre protocol require Oral rehydration therapy
  • Patients with the ability to take the study product orally

Exclusion Criteria:

• History of allergy, idiosyncrasy, hypersensitivity or adverse reactions to the active principle or to any of the excipients.

  • History or evidence of any medical conditions or medication used that, in the opinion of the principal investigator, could affect the safety of the subjects or interfere with the study evaluations
  • Patients in situation of last days
  • Amytriptilin and masalazine treatment (anti-depressives)
  • Laxatives